Copyright medicaldialogues
Mumbai: Cipla Limited has announced the elevation of Achin Gupta, currently the Global Chief Operating Officer, as the company's next Managing Director (MD) and Global Chief Executive Officer (GCEO) effective April 1, 2026, for a tenure of 5 years. The appointment will be proposed to the shareholders for their approval. He has been appointed as MD & GCEO Designate from January 1st, 2026. Achin will succeed Umang Vohra, who has served as the MD & GCEO of Cipla since 2016. Achin Gupta has been serving as the GCOO of the Company since February 2025, overseeing Commercial markets, API, Manufacturing, and Supply Chain. He joined Cipla in 2021 as the CEO of the One India business and has been an integral member of the Management Council. He has driven strong growth, expanded Cipla’s reach in chronic therapies and underserved geographies, and strengthened its core operations. Under his leadership, the India business delivered market-leading profitability, modernized its retail force, and introduced consumerfocused innovations. Achin also forged strategic global partnerships, positioning Cipla as a preferred innovation-led collaborator.Before joining Cipla, Achin held several roles at Glenmark Pharmaceuticals and Abbott Laboratories. He holds a M Tech degree from IIT Delhi, specializing in Biochemical Engineering and Biotechnology and an MBA from IIM, Ahmedabad. In over two decades of his career, Achin has built a strong track record as an entrepreneurial leader. Achin is known for building new frontiers and fostering a culture of purpose, innovation, and accountability. Umang Vohra who joined Cipla in 2015 as Global Chief Financial & Strategy Officer and thereafter served as Cipla’s MD & GCEO since 2016. Speaking on the announcement, Dr YK Hamied, Chairman, Cipla Limited said, “I thank Umang for his stewardship over the last ten years, his outstanding contributions and dedication to Cipla’s purpose of Caring for Life and combining business with a humanitarian approach. We wish Umang continued success in his future career. We are pleased to welcome Achin Gupta as he steps into this role, and I am confident he will lead Cipla to its next phase of progress and growth.Speaking on the occasion, Umang Vohra (current MD & GCEO) said, “My ten years at Cipla has been filled with immense pride in what we’ve built together. Guided by our purpose of Caring for Life, I have had the privilege of working with passionate teams who consistently put patients first and drive innovation across the business. I’m deeply grateful to our Chairman, Dr Y K Hamied, and the Board for their trust and support throughout this journey. As I prepare to hand over the reins, I’m confident that Achin Gupta will lead Cipla forward with vision and purpose. I look forward to supporting him and the leadership team to ensure a smooth transition. Achin Gupta (MD & GCEO Designate effective Jan 1, 2026) stated, “It is an honour to be entrusted with the responsibility of leading Cipla as its next MD & GCEO. Cipla’s legacy of purpose-driven innovation and patient-centric care is deeply inspiring, and I am committed to building on the strong foundation laid by Umang and the leadership team. Over the past few years, I’ve had the privilege of working closely with teams across the organization and witnessing firsthand the passion, resilience, and commitment that define Cipla. As we move forward, my focus will remain on driving sustainable growth, deepening our impact across markets, and continuing to innovate with purpose."Read also: Leadership Shift at Cipla: Umang Vohra to Exit, Achin Gupta Likely to Take Over as Global CEO
